Search

The hypothesis that stem cells may seed cancer has emerged from the cancer stem cells concept. However, the experimental systems necessary to provide more direct evidence to support the hypothesis have been lacking. We have used fetal neural progenitor cells (hNPC) transduced with the telomerase hTERT gene to investigate the neoplastic potential of hNPCs. The hTERT-transduced line, hNPCs-G3 lost normal diploid karyotype, showed loss of contact inhibition, anchorage independence, and formed neuroblastoma-like tumours in all of 10 mice. These data suggest that hNPCs have the potential for neoplastic transformation. These data have implications for providing a novel tool to test the feasibility of new anticancer treatment strategies and raise the possibility of a risk for the use of hNPCs in cell transplantation.

The nude mouse has been successfully employed for the propagation of human tumors, without the need for immunosuppression. In light of the limited data on embryonic gene expression in such tumors, we undertook a study of fetal isoenzyme expression during tumor growth. HeLa TCRC-1 which has been shown to produce the placental Regan isoenzyme was used in these studies. The isoenzyme produced by these cells in culture is initially replaced by an isoenzyme referred to as chorionic. In the later stages of tumor growth, the so-called oncoamniotic (FL) isoenzyme then becomes the dominant enzyme form. The chorionic isoenzyme is produced by the early chorionic membranes of the developing conceptus, while the oncoamniotic (FL) isoenzyme is most similar to that found in the fetal human intestine. The alteration in the expression of fetal isoenzymes in tumors growing in the nude mouse is similar to that seen in the immunosuppressed rat and hamster host animals, indicating that the phenomenon is not related to immunosuppression per se.